Article Listing - US FDA approves Alkermes’ Vivitrol to treat opioid-dependent patients and orphan status for PharmaLink’s Nefecon

9 March 1992

In contrast to specialist drug firms such as Innothera, which successfully exploit a niche in the drug market, generalist pharmaceutical...

9 March 1992

Six years after the first share floatation in UK drugmaker Wellcome, the Wellcome Trust has revealed that a further tranche...

9 March 1992

In the UK, pharmaceutical concern Lundbeck says it is set for a healthy future following its latest annual results. For...

9 March 1992

The French drug manufacturer, Innothera, which specializes in products for women's diseases, says it is ready to open its capital...

9 March 1992

Promotion of the neurone-specific calcium channel blocker Nimotop (nimodipine) in the USA by Miles Laboratories for the unapproved indication of...

9 March 1992

Sponsors of legislation now in the Senate which would reduce the market monopoly enjoyed by orphan drug makers fear that...

9 March 1992

Medeva plc and its subsidiary Evans Medical have launched in the UK a new product in the Coracten (nifedipine) range....

9 March 1992

Massachusetts-based company Epigen Inc has signed an agreement with investigators at the University of Oslo, Norway, to characterize the HC...

9 March 1992

Syntex Corp has received approval from the US Food and Drug Administration to market its Cardene SR, a slow-release formulation...

9 March 1992

John Gillard has been appointed as director of therapeutic research at BioChem Pharma Inc of Canada. 1614869 COST CONTAINMENT MEASURES...

Showing 94721-94730 of 95321 articles